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Abstract
Background: The continuing emergence of antimicrobial resistance requires the development of new compounds
and/or enhancers of existing compounds. Genes that protect against the lethal effects of antibiotic stress are
potential targets of enhancers. To distinguish such genes from those involved in drug uptake and efflux, a new
susceptibility screen is required.
Results: Transposon (Tn5)-mediated mutagenesis was used to create a library of Escherichia coli mutants that was
screened for hypersensitivity to the lethal action of quinolones and counter-screened to have wild-type
bacteriostatic susceptibility. Mutants with this novel “hyperlethal” phenotype were found. The phenotype was
transferable to other E. coli strains by P1-mediated transduction, and for a subset of the mutants the phenotype
was complemented by the corresponding wild-type gene cloned into a plasmid. Thus, the inactivation of these
genes was responsible for hyperlethality. Nucleotide sequence analysis identified 14 genes, mostly of unknown
function, as potential factors protecting from lethal effects of stress. The 14 mutants were killed more readily than
wild-type cells by mitomycin C and hydrogen peroxide; nine were also more readily killed by UV irradiation, and
several exhibited increased susceptibility to killing by sodium dodecyl sulfate. No mutant was more readily killed by
high temperature.
Conclusions: A new screening strategy identified a diverse set of E. coli genes involved in the response to lethal
antimicrobial and environmental stress, with some genes being involved in the response to multiple stressors. The
gene set, which differed from sets previously identified with bacteriostatic assays, provides an entry point for
obtaining small-molecule enhancers that will affect multiple antimicrobial agents.
Background
The emergence of antimicrobial resistance is severely
limiting treatment options for many important infec-
tious diseases [1,2]. Traditionally the problem of antimi-
crobial resistance has been approached by developing
new compounds having increased potency. Unfortu-
nately, development of new compounds is not keeping
pace with the emergence of antibiotic-resistant patho-
gens. Consequently, new strategies are needed to pre-
serve existing agents. One approach is to seek
compounds that will enhance the activity of distinct
antimicrobial classes by blocking resistance mechanisms.
For example, b-lactamase inhibitors extended the utility
of b-lactams when delivered as combinations such as
Augmentin (amoxicillin-clavulanic acid) [3], and
inhibitors of efflux pumps produced synergistic inhibi-
tion of growth against tetracycline-resistant Escherichia
coli when used in combination with doxycycline [4].
The conventional strategy has been to identify genes
whose inactivation increases the ability of compounds to
block bacterial growth (decreases in minimal inhibitory
concentration, MIC) [5]. Since some compounds kill
bacteria by processes that are distinct from bacterio-
static action [6,7] and since deficiencies in repair of
lethal damage may not affect bacterial growth, the possi-
bility exists that genes involved in bacterial survival are
distinct from those that protect from growth inhibition.
Finding genes whose products protect from the lethal
effects of stress requires screening procedures that differ
from those used for bacteriostatic effects.
In the present work, we used the prototype quinolone,
nalidixic acid, as a probe for screening genes whose pro-
ducts protect E. coli from lethal effects of stress.
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because bacteriostatic and lethal action are distinct
events that are sensitive to different drug concentrations
(for review see [8]). Mutants of E. coli, obtained by Tn5-
mediated insertional mutagenesis, were screened for
those that had the same bacteriostatic susceptibility to
nalidixic acid as the wild-type strain while exhibiting
greater sensitivity to the lethal action of the drug. We
call this new phenotype hyperlethality. With this pheno-
type we could eliminate from consideration mutants
with altered drug uptake, efflux, and target interactions,
since these properties affect bacteriostatic activity. The
decreased survival of the mutants was expected in some
cases to arise from disruption of genes involved in pro-
tecting from lethal stress. The hyperlethal mutants were
then examined by measuring the lethal action of several
other antimicrobial and environmental stresses. This
work defined a novel bactericidal phenotype and identi-
fied a diverse set of poorly characterized bacterial stress-
response genes as a new source of potential targets for
antimicrobial enhancement.
Methods
Bacterial strains and growth conditions
Bacterial strains were derivatives of E. coli K-12. Strain
AB1157 (isolate KD1045) [9] was used to construct the
Tn5-insertion library. Strain DM4100 [10] was used to
confirm the hyperlethal phenotype following P1-
mediated transduction, which was carried out according
to a standard procedure [11]. In this method P1 phage
lysates were prepared using the insertion mutants as
donors, and the lysates were then used to infect strain
DM4100 at a multiplicity of infection of 0.2. Transduc-
tants were recovered by growth on LB plates containing
25 μg/ml of kanamycin and 0.01 M sodium citrate.
Kanamycin-resistant transductants were tested for the
hyperlethal phenotype with nalidixic acid. Bacterial cells
were grown at 37°C either in LB broth or on LB agar
plates [11].
Antibacterial agents
All chemicals were from Sigma-Aldrich Corp. (St Louis,
MO, USA). Stock solutions of nalidixic acid were pre-
pared by dissolving in 0.1 N NaOH to yield a final con-
centration of 10 mg/ml. Other antibiotics were dissolved
in distilled water except for tetracycline and mitomycin
C, which were dissolved in 50% and 70% ethanol,
respectively. Mitomycin C was freshly prepared before
use; other antimicrobials were stored as concentrated
stock solutions at -80°C.
Library construction and screening
Bacteriophage lambda Tn5-tac was prepared from E.
coli BD1527 [12] according to a standard procedure
[13], and Tn5 hopping was carried out with strain
AB1157 as follows: recipient cells were grown to mid-
log phase (OD600 = 0.3 ~0.5), recovered by centrifuga-
tion (6,000 × g, 5 min), and resuspended in ice-cold LB
liquid medium containing 0.01 M magnesium sulfate.
Cells were then infected with lambda Tn5-tac at a mul-
tiplicity of infection of about 1 and incubated for 15
min at 37°C. After incubation, fresh LB medium was
added, and the cells were incubated for 2 hr at 37°C for
expression of kanamycin resistance. Cells were then pla-
ted on LB-agar plates containing 25 μg/ml of kanamy-
cin. After incubation overnight at 37°C, kanamycin-
resistant colonies were tested individually for nalidixic
acid susceptibility (MIC) and lethality as described
below. Mutants that were more readily killed by treat-
ment with nalidixic acid at 20 μg/ml or 50 μg/ml for 2
hr but had MICs close to wild-type levels were consid-
ered to have a hyperlethal phenotype; they were selected
for further analysis.
Determination of antimicrobial susceptibility and lethality
Antimicrobial susceptibiltiy (MIC99)w a sd e f i n e da st h e
minimal concentration of antimicrobial agents that
inhibited growth of 99% of the input cells. MIC99 was
measured by applying 10 μl of serial dilutions of mid-
log phase cultures (OD600 = 0.3 ~0.5) in triplicate to LB
agar plates containing various concentrations of antimi-
crobials. Colonies were counted after overnight incuba-
tion at 37°C. The fraction of colonies recovered (relative
to the CFU per ml on drug-free plates) was plotted
against drug concentration, and MIC99 was determined
by interpolation.
To measure lethality, cells were grown in LB liquid
medium to mid-log phase (OD600 =0 . 3~ 0 . 5 )a t3 7 ° C
with shaking. Cells were split into 1-ml aliquots in test
tubes, and various concentrations of antimicrobial
agents (2 × MIC99 to 30 × MIC99) were added. After
incubation for 2 hr with shaking, cells were diluted in
LB liquid medium, which eliminated drug carryover,
and 10 μl of aliquots from the dilutions were spotted in
triplicate on drug-free LB agar plates. Colonies were
counted after overnight incubation at 37°C. Lethality
was expressed as percent of control relative to the CFU
per ml at the time of drug addition. The dose that
reduced CFU by 90% was taken as LD90.
For screening the mutant library, kanamycin-resistant
colonies were manually replica-plated with toothpicks to
a series of plates containing various concentrations of
nalidixic acid and incubated overnight. Colonies exhibit-
ing the same bacteriostatic susceptibility as the parental
strain were saved for lethality measurement. Survival for
each colony was measured in liquid medium after a 2-hr
incubation in nalidixic acid at 20 μg/ml and 50 μg/ml as
described in the previous paragraph. Colonies that
exhibited decreased survival relative to the parental
strain were then retested for MIC and survival as
described in the previous paragraphs. Strains confirmed
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ized as described below.
Identification of gene insertion sites
Asymmetric PCR, modified from that described pre-
viously [14-16], was used to amplify E. coli genomic
sequences near the ends of Tn5 that inserted into the
genome. One primer, either Tn5R10 (5’ GGG ATC
CCC TAC TTG TGT AT 3’) or Tn5F4568 (5’ AGA
ATT CCT CCC GAG ATC TG 3’) was complementary
to the sequence at an end of Tn5; the other primer con-
t a i n e da6 - n u c l e o t i d er a n d o ms e q u e n c ef o l l o w e db y
TGGC (Ran5-29: 5’ GTT CTA CAC GAG TCA CTG
CAG NNN NNN TGG C 3’). The randomized primer
binds any GCCA in the genome. However, since PCR
preferentially amplifies short fragments, combination of
the two primers should amplify the sequences between
o n eT n 5e n da n dt h ef i r s tf e wG C C As e q u e n c ee l e -
ments. For the first 5 cycles of PCR, the annealing tem-
perature was high (58°C); consequently, the primer that
was complementary to the sequence at the Tn5 end pre-
ferentially bound to the substrate, which caused one
strand of the substrate to be asymmetrically amplified.
This high-temperature annealing was followed by a
cycle using low annealing temperature (30°C) to allow
the randomized primer to bind the strand that had
already been amplified. Then one high-temperature (58°
C) and one moderate-temperature (44°C) cycle were
alternated 12 times to amplify the sequence between the
two primers. For all amplification cycles, the annealing
time was 1 min, while the denaturation (94°C) and
extension (72°C) times were 15 sec and 2 min, respec-
tively. The nucleotide sequence was then determined for
PCR products that exhibited single bands following
agarose gel electrophoresis. In some cases, the products
of the first PCR were further amplified with repeated
alternation of one high annealing temperature (58°C)
cycle and one moderate annealing temperature (44°C)
cycle in which the randomized primer was replaced with
primer Fix5-29-2 (5’ CTA CAC GAG TCA CTG CAG
3’), a primer sequence that was identical to 18 of the 21
5’ terminal nucleotides of the randomized primer. DNA
sequences obtained were used as query probes to search
the E. coli K-12 genome sequence database for identify-
ing transposon insertion sites.
Lethality of environmental stresses
The susceptibility of bacterial cells to UV irradiation was
tested by applying serial dilutions of mid-log phase
(OD600 = 0.3 ~0.5) cultures to agar plates that were irra-
diated with an Ultraviolet Crosslinker CL-1000 (UVP) at
ad o s eo f2 0 0 0μJ/cm
2 in a dark room. The plates were
then covered with aluminium foil and incubated over-
night at 37°C. For other stressors, mid-log phase cells
were treated with 2 mM H2O2 (cells were resuspended
in 0.9% saline before treatment), 10% sodium dodecyl
sulfate (SDS), or high temperature (52°C) for 15 min.
Serial dilutions were then prepared, and 10-μlo fa l i -
quots from the dilutions were spotted in triplicate on
plates and incubated at 37°C overnight. The sensitivity
of cells to the lethal effects of these stressors was
expressed as percent survival of treated cells relative to
that of untreated cells determined at the time of treat-
ment (LD90 could not be used because many of the
mutant-stressor combinations did not reduce survival
sufficiently).
Complementation of hyperlethality by cloned genes
All DNA manipulations were carried out according to
procedures described previously [13]. The emrK and
ycjU genes with their promoter regions were amplified
by PCR using chromosomal DNA isolated from
DM4100 as templates and cloned into pBR322. The pri-
mers used were 5’-TAG GAA TTC ATC TCC CTT
CTC CCT GTA GT-3’ and 5’-TAA GTC GAC ATT
CTT TGT GCC AAC CTG-3’ for emrK,a n d5 ’-TGC
GAA TTC CTG CTG ACC CAA AGT TAT-3’ and 5’-
TAG CTG CAG TCA CCT CTT TGG CGA TT-3’ for
ycjU. Plasmids containing wild-type ycjW, yrbB,a n d
ybcM were from the ASKA library [17]. The plasmids
were placed in the corresponding mutant strains, as well
as in the wild-type strain DM4100, by electroporation.
The strains harboring the plasmids were then tested for
nalidixic acid lethality. For ycjW, yrbB,a n dybcM,t h e
expression was induced by adding 1 mM of IPTG 2 hr
before nalidixic acid treatment.
Results and Discussion
Screening for mutants exhibiting hyperlethality to
nalidixic acid
D u r i n gt h ec o u r s eo fe v o l u t i on, bacteria have acquired a
variety of genetic networks that provide protection from
stress. For example, in E. coli more than 30 two-compo-
nent systems detect the environment and cause changes
in the expression of large numbers of genes [18]. To find
genes that are specifically involved in protecting from the
lethal action of antibiotics, as opposed to genes that sim-
ply limit drug uptake or enhance efflux, we screened a
library of transposon-generated mutants for a hyperlethal
phenotype (more readily killed by nalidixic acid with no
change in bacteriostatic susceptibility, MIC). From about
800 insertion mutants we recovered 14 that exhibited the
phenotype. To establish that the hyperlethal phenotype
arose from transposon insertion, each of the mutations
was transferred to a second strain of E. coli by P1-
mediated transduction. Transductants from each mutant
strain were more readily killed by nalidixic acid (Fig. 1)
while displaying less than a 2-fold variation in MIC99
relative to the wild-type parent (Table 1). Thus, the Tn5-
insertion was necessary and sufficient for the hyperlethal
phenotype with all 14 mutants tested.
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asymmetric PCR was used to amplify the sequences
near the ends of Tn5 using a protocol modified from
previously published reports [14-16]. Nucleotide
sequence determination of the PCR products then iden-
tified 14 different genes (Table 1). Only one of these
genes (ycjU, also called pgmB) appeared in the list of
genes identified previously as being involved in affecting
the bacteriostatic action of quinolones [5]. The ycjU
m u t a t i o nc a u s e dc e l l st ob eo n l ys l i g h t l ym o r es u s c e p t i -
ble to nalidixic acid than the wild-type strain in our bac-
teriostatic measurement (Table 1, MIC99 4.1 μg/ml vs.
4.5 μg/ml). Thus, ycjU may not belong in the set pre-
viously identified as having a low MIC [5]. The two-fold
drop in LD90,f r o m5 9μg/ml to 31 μg/ml (Fig. 1), quali-
fied it as a gene with a hyperlethal phenotype.
Mutant susceptibility to other antimicrobial agents and
environmental stressors
To determine whether the hyperlethal phenotype was
restricted to quinolones, we examined the response of
the mutants to a variety of other stresses. When tetracy-
cline was tested, we found that, except for two strains
Figure 1 Antimicrobial susceptibilities of insertion mutants. E.
coli cultures grown to mid-log phase were treated with various
concentrations of antimicrobial agents for 2 hr at 37°C. Bactericidal
activity was expressed as percent survival relative to the CFU per ml
at the time of drug addition. The concentration that reduced CFU
by 90% was taken as LD90. The values are the means of 3
independent experiments. Error bars indicate standard deviations of
means.
Table 1 Properties of genes that reduce the lethal effects
of stress.
Strain MIC99 of Nal
(μg/ml)
a
Site of
insertion
Functional annotation of
disrupted genes
DM4100 4.5 ± 0.3 NA (wild-
type)
NA
TL17 3.1 ± 0.1 yadC Fimbrial-like protein
TL18 4.6 ± 0.3 ycdO Putative lipoprotein
TL19 4.2 ± 0.6 yibA Predicted lyase containing HEAT-
repeat
TL20 4.6 ± 0.4 rfbX RfbX lipopolysaccharide PST
transporter
TL21 4.8 ± 0.2 rfbC dTDP-4-deoxyrhamnose-3,5-
epimerase
TL22 4.7 ± 0.1 ybdA Permease (major facilitator
superfamily (MFS) of
transporters)
TL23 3.7 ± 0.3 yfbQ Predicted aminotransferase
TL24 3.3 ± 0.2 ykfM Predicted protein
TL25 3.0 ± 0.2 yrbB Predicted NTP-binding protein
TL26 5.3 ± 0.3 ybcM ARAC-type regulatory protein
TL28 3.4 ± 0.1 ycjW Putative LACI-type transcriptional
regulator
TL157 4.1 ± 0.5 ycjU Putative b-phosphoglucomutase
TL158 4.0 ± 0.6 emrK Putative membrane fusion
protein
TL162 4.4 ± 0.6 emrY Putative multidrug MFS
transporter
aMIC99 was measured by applying serial dilutions of mid-log phase cultures to
agar plates containing various concentrations of nalidixic acid followed by
incubation, colony number determination, and MIC99 estimation as described
in Methods. The values shown are the means of 3 independent experiments
with standard deviations as indicated. Abbreviations: Nal: nalidixic acid; NA:
not applicable.
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were more readily killed (LD90 was about half the wild-
type value, Fig. 1). Increased lethality was not observed
for the b-lactam ampicillin (Fig. 1). Thus, increased kill-
ing of the mutants by antimicrobial agents was not
restricted to quinolones, but it was also not universal.
When the DNA damaging agent mitomycin C was
tested, all of the mutants were more readily killed than
wild-type cells (for some genes LD90 was 10% of wild-
type values, many were in the 20 to 30% range, and two
were close to 50%, Fig. 1). More than half of the
mutants were more readily killed by UV irradiation than
the wild-type strain (Fig. 2). Genes not involved in pro-
tecting cells from the effects of UV irradiation were
rfbX, ybdA, yfbQ, ykfM,a n dycjW. Nine others were
involved in protecting cells from the effects of nalidixic
a c i d ,m i t o m y c i nC ,a n dU V .T h u s ,m a n yo ft h eg e n e s
are involved in facilitating survival of E. coli cells
exposed to DNA-damaging agents.
The effect of hydrogen peroxide was also examined,
since it has recently been implicated in the lethal action
of multiple antibiotics [6,7]. After treatment with 2 mM
H2O2 for 15 min, all mutants showed decreased survival
compared to wild-type strain DM4100 (for many
mutants survival was 20 to 30% that of the wild-type
strain, Fig. 2). We also examined the effects of two
other environmental stresses, exposure to high tempera-
ture and to the ionic detergent sodium dodecyl sulfate
(SDS). When the set of mutants was exposed to high
temperature (52°C), no substantial difference among the
mutants was observed for heat-induced death (Fig. 2).
With 10% SDS, the effect of the mutations on survival
varied. Some mutants (yadC, ybdA, yfbQ, ykfM, yrbB,
ybcM,a n demrK) were less susceptible to killing than
wild-type E. coli, while ycdO, yibA,a n drfbC mutants
were more readily killed (Fig. 2).
In summary, 14 mutant genes were associated with
hyperlethality to nalidixic acid and were more readily
killed by mitomycin C and peroxide; 9 were more read-
ily killed by UV irradiation. Only 3 of the mutants were
more readily killed by SDS, none by high temperature.
Below we consider what has been reported previously
about the diverse set of genes identified by our screen-
ing procedure. None of that information leads to an
expectation of hyperlethality to nalidixic acid.
Putative function of genes exhibiting hyperlethality to
nalidixic acid
Eight of the mutant genes (yadC, rfbX, rfbC, ycdO, yrbB,
ybdA, emrK,a n demrY) were annotated in Genbank as
outer membrane proteins or proteins whose function is
related to the outer membrane. The MIC99so ft h e s e
mutants for nalidixic acid were in the same range as
that of the wild-type strain; consequently, hyperlethality
caused by these mutations was unlikely to be due to
Figure 2 Susceptibilities of insertion mutants to physical and
chemical stresses. E. coli cultures grown to mid-log phase were
treated with 2000 μJ/cm
2 of UV; 2 mM H2O2, 10% SDS, or heat
shock at 52°C for 15 min. Samples were diluted, applied to agar
lacking stressor, and incubated to determine the fraction of colonies
surviving. This fraction was expressed as a percent of an untreated
control culture sampled at the time stress was applied. In the case
of SDS, some mutants grew during treatment, which caused those
samples to have values higher than the control. Values reported are
the means of 3 independent experiments. Error bars indicate
standard deviations of means.
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involved in protecting from the effects of nalidixic acid,
mitomycin C, and hydrogen peroxide, it is likely that
protection from UV irradiation also occurred at the
level of downstream effects of irradiation rather than
through screening cells from UV light.
The yadC mutant, which was among the more sensi-
tive to DNA damaging agents, was considerably less
sensitive than the wild-type strain to SDS. YadC is a
fimbrial-like protein whose amino acid sequence sug-
gests that it may contain b-barrel structure(s) [19]. In E.
coli, pili are adherence factors that could, in principle,
protect some cells in a population from antimicrobial
treatment. However, we detected no difference with
respect to cellular aggregation when the yadC mutant
and the wild-type strain, growing exponentially, were
examined by light microscopy (not shown). Thus, the
hyperlethal phenotype of the mutant was not likely to
be due to lack of cellular self-association. yadC is
induced immediately after exposure to the biocide poly-
hexamethylene biguanide [20], which is consistent with
its involvement in a cellular response to stress.
The two rfb mutants were strikingly different in their
response to UV: the rfbX mutant showed little effect,
while the rfbC mutant was one of the most susceptible
(Fig. 2). RfbX, also known as WzxB, is a member of the
polysaccharide transporter (PST) family [21], and hydro-
pathy analysis suggests that RfbX has 12 transmembrane
segments [22]. rfbC encodes dTDP-4-dehydrorhamnose
3,5-epimerase [23]. Although the rfb genes are thought
to be involved in O-antigen biosynthesis in enteric bac-
teria, such as Salmonella, Shigella, Klebsiella,a n ds o m e
serovars of E. coli [24], that feature may be irrelevant to
the current work, since E. coli K-12 does not normally
express a functional O-antigen due to defects in the rfb
gene cluster [25,26]. The fact that rfbX is induced when
treated with polyhexamethylene biguanide [20] suggests
that it may be involved in a cellular stress response.
The ycdO mutant was the most readily killed by UV
irradiation (Fig. 2). YcdO is a monomeric, membrane-
associated protein that contains a type I signal peptide
and is transported to the periplasm with high efficiency
[27]. Since YcdO is induced at low pH due to phosphor-
ylation of the CpxR component of the CpxAR two-com-
ponent response regulator [28-30], it may be involved in
bacterial envelope stress responses mediated by the
CpxAR pathway.
YrbB(MlaB) is predicted to be a nucleotide-binding
protein that contains a STAS domain [31]. YrbB is a
component of an ABC transport system that maintains
lipid asymmetry in the Gram-negative outer membrane
by preventing surface exposure of phospholipids [32].
Although the YrbB mutant is more sensitive than the
wild-type strain to the presence of EDTA-SDS, it does
not show hypersusceptibility to erythromycin, rifampi-
cin, bacitracin, or novobiocin [32]. These data indicate
that the yrbB mutation does not change the permeabli-
lity to most compounds, which is consistent with our
finding that the yrbB mutation did not change the bac-
teriostatic effects of nalidixic acid.
ybdA, emrK, and emrY are postulated to encode efflux
pumps, although MIC determinations with nalidixic acid
showed no evidence that the mutations affected efflux
(Table 1). The YbdA protein is a member of the major
facilitator superfamily (MFS) of transporters [33], while
EmrK and EmrY show sequence similarity to members
of the EmrAB-TolC drug efflux system. The two emr
mutants were exceptionally sensitive to mitomycin C
(Fig. 1), UV irradiation, and H2O2 (Fig. 2). The ybdA
and emrK mutants were among the least susceptible to
the lethal effects of SDS (Fig. 2), as expected of efflux
mutants. Perhaps the ErmK, ErmY, and YbdA proteins
normally pump out toxic metabolites induced by DNA
damage.
Two genes,ybcM and ycjW,a r ep r e d i c t e dt ob e
involved in cell regulation. YbcM is a putative DNA-
binding transcriptional regulator that is induced by the
biocide polyhexamethylene biguanide [20]; in Yersinia
enterocolitica a homolog of ybcM is induced by low
temperature [34]. These properties are consistent with
YbcM being involved in bacterial stress responses. YcjW
is a putative LacI-type transcriptional regulator.
Although the biological role of YcjW is unknown, ycjW
transcripts accumulate in a strain harboring wild-type
relA but not in a relA mutant after treatment with 4-
azaleucine, an inhibitor that interferes with translation
[35]. These data suggest that YcjW may be involved in
the bacterial stringent response.
Three other genes, ycjU, yibA, and yfbQ,e n c o d ep u t a -
tive cytosolic proteins of unknown function. The ycjU
mutant is among the most sensitive to UV irradiation
(Fig. 2). YcjU has been annotated in sequence data bases
as a putative b-phosphoglucomutase that belongs to the
superfamily of haloacid dehalogenase (HAD)-like hydro-
lases. In vitro, YcjU hydrolyzes small phosphodonors
[36], which suggest that the protein is likely to have
other physiological roles. The yibA mutant was among
the most sensitive to UV irradiation and H2O2 (Fig. 2).
YibA is a predicted lyase containing a HEAT-repeat,
which forms a rod-like helical structure in proteins.
Transcription profiling experiments suggested that yibA
may belong to the s
32 regulon [37], whose genes are
expressed in E. coli in response to heat shock. Thus, the
role of YibA in antimicrobial susceptibility may be
exerted through alternative sigma factor-regulated stress
responses. However, the yibA mutant was not particu-
larly sensitive to high temperature. A third mutant, in
yfbQ, was the most sensitive to mitomycin C. The only
Han et al. BMC Microbiology 2010, 10:35
http://www.biomedcentral.com/1471-2180/10/35
Page 6 of 9information available refers to the gene product as a
potential aminotransferase.
Reactive oxygen species-mediated response to lethal
antimicrobials
Although no clear metabolic connection exists among
the genes we identified, some guidance can be gained
from the recent proposal that lethal antimicrobials
share a common cell death pathway involving a reactive
oxygen cascade [6,7]. The lethal activity of a variety of
antimicrobials, including the fluoroquinolone norfloxa-
cin, is accompanied by an increase in hydroxyl radical,
and lethal activity is greatly reduced by treating E. coli
cells with agents that block the accumulation of hydro-
xyl radical [6]. The idea emerged that lethal antimicro-
bials act in part by generating a signal that causes an
accumulation of superoxide, which reacts with iron-sul-
fur clusters to release peroxide and iron. Peroxide and
iron then form highly toxic hydroxyl radicals through
the Fenton reaction. Superoxide can also be converted
to peroxide by superoxide dismutase and by sponta-
neous dismutation. The resulting increase in peroxide
would contribute to the formation of hydroxyl radical.
In support of this idea, we found that deletion of both
superoxide dismutase genes reduced the lethality of nor-
floxacin [38]. As expected, a deficiency of catalase,
which converts peroxide to water, led to an increase in
the lethality of norfloxacin [38]. Mutations in genes that
normally protect from the accumulation of reactive oxy-
gen species would be recovered by our screen for
hyperlethality to nalidixic acid. Such mutants are
expected to also be more readily killed by other DNA
damaging agents, such as mitomycin C, peroxide, and
UV irradiation, as seen for 9 of the 14 of the genes we
identified.
Complementation of hyperlethality by cloned genes
To determine whether the hyperlethal phenotype of
the mutants was caused by deficiency of the mutant
genes rather than polar effects due to Tn5 insertion,
we selected several mutants for complementation using
wild-type genes cloned into plasmids. We focused on
representatives from three groups (membrane and
related proteins (emrK, yrbB), cytosolic enzymes
(ycjU), and regulators (ycjW, ybcM)). In each case,
complementation was observed (Fig. 3). Thus, at least
for this selection of genes it is likely that the gene pro-
ducts contributed to reducing the lethal effects of nali-
dixic acid. While these data do not assure that
complementation will occur in the other cases, they
give us confidence to move forward with the study of
the bacterial response to lethal stress. We note in
some cases paradoxical survival occurred at high con-
centrations of nalidixic acid. This phenomenon, which
is unexplained, is commonly observed with quinolones
[39].
Figure 3 Complementation of hyperlethal phenotype by
cloned genes. Plasmids containing wild-type genes were
transformed into the corresponding Tn5-containing mutants. The
strains harboring the plasmids were then tested for nalidixic acid-
mediated lethality by treating mid-log phase cells with various
concentrations of nalidixic acid for 2 hr at 37°C. Percent of control
indicates percent survival of treated cells relative to untreated cells
sampled at the time of drug addition. For ycjW, yrbB, and ybcM, the
expression was induced by adding 1 mM of IPTG 2 hr before
nalidixic acid treatment. Similar results were obtained in a replicate
experiment.
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The present work described a novel screening process
for identifying genes involved in protecting E. coli from
quinolone-mediated death due to events occurring after
formation of quinolone-gyrase-DNA complexes. Using
this screen we identified 14 poorly characterized genes.
Scattered evidence suggests that many of these genes
are linked to protective stress responses, which is sup-
ported by our finding that mutations in these putative
protective genes resulted in decreased survival following
treatment with several stressors. The diverse set of
genes described may serve as potential targets for future
screening of small-molecule antimicrobial potentiators.
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